investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Optimization of adoptive immunotherapy with autologous CD20-specific T cells

Brian Till

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

No posts

Related projects

Ronald Anthony Depinho

Telomerase in Development, Senescence and Neoplasia

Non-Hodgkin lymphoma

Leo Masamba

Breast Cancer Receptor Study : Targeting HIV Associated Lymphoma in Malawi

Non-Hodgkin lymphoma

Ulf Klein

The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Gregory J Hannon

Cold Spring Harbor Laboratory Cancer Research Center

Non-Hodgkin lymphoma

Hesham M Amin

Role of IGF-IR tyrosine kinase in NPM-ALK-expressing T-cell lymphoma

Non-Hodgkin lymphoma

Christopher J Ott

Chemical Modulation of Chromatin Signaling in Lymphoid Malignancies

Non-Hodgkin lymphoma

Mary Ellen Conley

Genetic Etiology of Agammaglobulinemia with Absent B Cells

Non-Hodgkin lymphoma

Laura Pasqualucci

Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies